ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.295
-0.73%
US Dollar vs AUD
1.5196
1.35%
Bitcoin
69,007.71
-2.48%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oncocyte Corporation (OCX)

  7. Oncocyte Corporation (OCX) News

OCX

Oncocyte (OCX)

Oncocyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OCX
DateTimeSourceHeadlineSymbolCompany
05/06/202407:02Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
04/06/202404:13GlobeNewswire Inc.Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft StudyNASDAQ:OCXOncocyte Corporation
01/06/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
31/05/202406:47GlobeNewswire Inc.Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of MedicineNASDAQ:OCXOncocyte Corporation
24/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
24/05/202401:26Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
23/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
23/05/202407:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
23/05/202406:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
18/05/202407:11Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:OCXOncocyte Corporation
16/05/202406:05GlobeNewswire Inc.Oncocyte Reports First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
13/05/202422:00GlobeNewswire Inc.Oncocyte to Announce First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
11/05/202407:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCXOncocyte Corporation
07/05/202423:19GlobeNewswire Inc.PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics MarketplaceNASDAQ:OCXOncocyte Corporation
12/04/202420:00GlobeNewswire Inc.Oncocyte Reports Full Year 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
12/04/202411:46GlobeNewswire Inc.Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesNASDAQ:OCXOncocyte Corporation
12/04/202407:30GlobeNewswire Inc.Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayNASDAQ:OCXOncocyte Corporation
10/04/202406:05GlobeNewswire Inc.Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
24/01/202408:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
17/01/202400:00GlobeNewswire Inc.Oncocyte to Present at the Sequire Investor Summit in Puerto RicoNASDAQ:OCXOncocyte Corporation
07/12/202300:00GlobeNewswire Inc.Oncocyte Begins FDA Submissions Process for VitaGraft Transplant AssaysNASDAQ:OCXOncocyte Corporation
10/11/202309:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
09/11/202323:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
09/11/202323:00GlobeNewswire Inc.Oncocyte Reports Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
03/11/202323:30GlobeNewswire Inc.Oncocyte to Announce Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
13/10/202307:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
11/10/202307:48Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OCXOncocyte Corporation
06/10/202307:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
20/09/202323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
29/08/202306:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
 Showing the most relevant articles for your search:NASDAQ:OCX

Your Recent History

ASX
FMG
Fortescue
NYSE
XOM
Exxon Mobil
ASX
XFL
S&P ASX 50
ASX
AMP
AMP
NYSE
KO
Coca Cola
ASX
WBC
Westpac Banking
COIN
ETHUSD
Ethereum
ASX
BHP
BHP
ASX
ANZ
Australia And New Zealan...
FX
EURAUD
Euro vs AUD
NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
ASX
WOW
Woolworths
ASX
NCM
Newcrest Mining
ASX
QBE
QBE Insurance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved